重组人干扰素-alpha2a/IFNa2aHuman Interferon-Alpha2aHumanRecombinantSYNONYMS
Leukocyteinterferon,Bcellinterferon,TypeIinterferon,IFNA2,IFN-a2a.
INTRODUCTION
IFN-alphaisproducedbymacrophagesandhasantiviralactivities.Interferonstimulatestheproductionoftwoenzymes:proteinkinaseandanoligoadenylatesynthetase.
DESCRIPTION
InterferonAlphaHuman2aRecombinantproducedinE.Coliisasingle,non-glycosylated,polypeptidechaincontaining165aminoacidsandhavingamolecularmassof19241Dalton.
TheInterferon-a2agenewasobtainedfromhumanleukocytes.
TheIFN-A2aispurifiedbyproprietarychromatographictechniques.
SOURCE
EscherichiaColi.
PHYSICALAPPEARANCE
SterileFilteredWhitelyophilized(freeze-dried)powder.
FORMULATION
Lyophilizedwithoutadditives.
SOLUBILITY
ItisrecommendedtoreconstitutethelyophilizedInterferon-alpha2ainsterile18MΩ-cmH2Onotlessthan100µg/ml,whichcanthenbefurtherdilutedtootheraqueoussolutions.
LyophilizedInterferonalpha2aalthoughstableatroomtemperaturefor3weeks,shouldbestoreddesiccatedbelow-18°C.UponreconstitutionIFN-alpha2ashouldbestoredat4°Cbetween2-7daysandforfutureusebelow-18°C.
Forlongtermstorageitisrecommendedtoaddacarrierprotein(0.1%HSAorBSA).
Pleasepreventfreeze-thawcycles.
PURITY
Greaterthan97.0%asdeterminedbyboth:
(a)AnalysisbyRP-HPLC.
(b)AnalysisbySDS-PAGE.
AMINOACIDSEQUENCE
ThesequenceofthefirstfiveN-terminalaminoacidswasdeterminedandwasfoundtobeCys-Asp-Leu-Pro-Gln,conformingtothesequenceofnativehumanIFN-a.
N-terminalmethioninehasbeencompletelyremovedenzymatically.
ThespecificactivityasdeterminedinaviralresistanceassayusingbovinekidneyMDBKcellswasfoundtobe270,000,000IU/mg.
PROTEINCONTENT
Proteinquantitationwascarriedoutbytwoindependentmethods:
1.UVspectroscopyat280nmusingtheabsorbencyvalueof0.924astheextinctioncoefficientfora0.1%(1mg/ml)solution.ThisvalueiscalculatedbythePCGENEcomputeranalysisprogramofproteinsequences(IntelliGenetics).
2.AnalysisbyRP-HPLC,usingacalibratedsolutionofIFN-a2aasaReferenceStandard.
REFERENCES
1.Title:Genderspecificityofalteredhumanimmunecytokineprofilesinaging.
Publication:PublishedonlinebeforeprintMay7,2010,doi:10.1096/fj.10-160911
September2010 TheFASEBJournal vol.24no.93580-3589
Link:http://www.fasebj.org/content/24/9/3580.full
2.Title: Differentialinvolvementof5-HT1Aand5-HT1B/1Dreceptorinhumaninterferona-inducedimmobility
Publication: Arzneimittel-Forschung 60.3(2009):109-115.
Link: http://www.ijppp.org/files/IJPPP905002.pdf
USAGE
Prospec"sproductsarefurnishedforLABORATORYRESEARCHUSEONLY.Theproductmaynotbeusedasdrugs,agriculturalorpesticidalproducts,foodadditivesorhouseholdchemicals.